Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

Teresa Cafaro, MD, Vicky Tagalakis, MD FRCPC, Maral Koolian, MD FRCPC, Simard Camille, MD

Blood (2019) 134 (Supplement_1): 2445.

https://doi.org/10.1182/blood-2019-128849

Published: 2019

Journal Articles

First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response

Blood (2018) 132 (Supplement 1): 4251.

https://doi.org/10.1182/blood-2018-99-110250

Published: 2018

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Gregory Sampang Calip, PharmD, MPH, PhD, Jifang Zhou, MD, Karen Sweiss, PharmD, Pritesh Patel, MD, Alemseged Ayele Asfaw, MSc, B Pharm, Todd Lee, PharmD, PhD, Brian C.-H. Chiu, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2018) 132 (Supplement 1): 4693.

https://doi.org/10.1182/blood-2018-99-116867

Published: 2018

Journal Articles

Risk Factors of Thromboembolic Disease in Men with Prostate Cancer: Report from a Hispanic Population

Rodrigo Luna-Santiago, MD, Maria T Bourlon, MD MHS, Ariel Jasqui-Bucay, Alan Jasqui-Bucay, Oscar Manuel Fierro-Angulo, MD, Jesus A Garcia-Ramos, MD, Guillermo Rosales-Sotomayor, Silvia Martiñon-Gutierrez, MD, Hugo E Velazquez, Carlos A Castro, Christianne Bourlon, MD

Blood (2018) 132 (Supplement 1): 5025.

https://doi.org/10.1182/blood-2018-99-120227

Published: 2018

Journal Articles

Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies

Daniel A. Pollyea, MD, Brett M. Stevens, PhD, Amanda Winters, MD PhD, Mohd Minhajuddin, PhD, Jonathan A Gutman, MD, Enkhtsetseg Purev, MD PhD, Clayton Smith, MD FRCPC, Diana Abbott, PhD, Craig T. Jordan, PhD

Blood (2017) 130 (Supplement 1): 181.

https://doi.org/10.1182/blood.V130.Suppl_1.181.181

Published: 2017

Journal Articles

Increased Fracture Risk in Patients with Untreated Chronic Lymphocytic Leukemia (CLL): A Population-Based Analysis

Adam J Olszewski, MD, Roee Gutman, PhD, Charles B Eaton, MD MS

Blood (2015) 126 (23): 878.

https://doi.org/10.1182/blood.V126.23.878.878

Published: 2015

Journal Articles

The Cardiovascular Impact of Carfilzomib in Multiple Myeloma

Allison C. Rosenthal, DO, Jennifer Luthi, RN BSN OCN, Marek Belohlavek, MDPhD, Farouk Mookadam, MB ChB, Angela Mayo, PA, Rafael Fonseca, MD, P. Leif Bergsagel, MD, Craig B. Reeder, MD, Joseph R. Mikhael, MD, Keith Stewart, MBA, MB, CHB

Blood (2014) 124 (21): 4748.

https://doi.org/10.1182/blood.V124.21.4748.4748

Published: 2014

Journal Articles

Treatment Outcomes in Pediatric Patients with Pulmonary Embolism Using Low Dose Tissue Plasminogen Activator Therapy

Chittalsinh M Raulji, MD, Mary Silverburg, Justin Farge, MD, Maria Velez, MD, Jaime Morales, MD

Blood (2014) 124 (21): 1547.

https://doi.org/10.1182/blood.V124.21.1547.1547

Published: 2014

Journal Articles

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer

Shruti Chaturvedi, MD, Surbhi Sidana, MD, Alok A. Khorana, MD, Keith R. McCrae, MD

Blood (2013) 122 (21): 3626.

https://doi.org/10.1182/blood.V122.21.3626.3626

Published: 2013

Journal Articles

A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

Steven I. Park, MD, Kristy L. Richards, MD PhD, Adam S. Asch, MD, Oludamilola Olajide, MBBS, Allison M. Deal, MS, Anastasia Ivanova, PhD, James G. Wall, MD, Anna L. Sobol, MD, Matthew C. Foster, MD, Hyman B. Muss, MD, Thomas C. Shea, M.D.

Blood (2013) 122 (21): 1791.

https://doi.org/10.1182/blood.V122.21.1791.1791

Published: 2013

Journal Articles

Incidence Of Symptomatic Venous Thromboembolism In Patients With Hemophilia Undergoing Joint Replacement Surgery: A Retrospective Study

Juliana Perez Botero, MD, Daniel B Spoon, MD, Mrinal M Patnaik, MBBS, Robert T Trousdale, MD, Rajiv K Pruthi, MBBS

Blood (2013) 122 (21): 2348.

https://doi.org/10.1182/blood.V122.21.2348.2348

Published: 2013

Journal Articles

Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin,

Eli Peled, MD, Alexie Robitzki, MD, Elena Axelman, MSc., Doron Norman, MD, Benjamin Brenner, MD, Yona Nadir, M.D., Ph.D

Blood (2011) 118 (21): 3333.

https://doi.org/10.1182/blood.V118.21.3333.3333

Published: 2011

Journal Articles

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Gregory M Pastores, Barry E Rosenbloom, MD, Neal J Weinreb, Ozlem Goker-Alpan, Rebecca Mardach, Mark Lipson, Jennifer Ibrahim, Gabriel M Cohn, David Zahrieh, Pramod K Mistry

Blood (2011) 118 (21): 1101.

https://doi.org/10.1182/blood.V118.21.1101.1101

Published: 2011

Journal Articles

Combination Therapy with Vorinostat and Bortezomib in Patients with High Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Erica D Warlick, MD, Qing Cao, MS, Jeffrey S. Miller, MD

Blood (2011) 118 (21): 4277.

https://doi.org/10.1182/blood.V118.21.4277.4277

Published: 2011

Journal Articles

Final Results of a Phase II Study of Sequential R-CHOP and Yttrium-90 Ibritumomab Tiuxetan (RIT) for Elderly High Risk Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL).

Paul A. Hamlin, Jr, MD, Maria Alma Rodriguez, MD, Ariela Noy, MD, Carol S. Portlock, MD, David Straus, MD, Peter McLaughlin, MD, Barbara Pro, MD, Luis Fayad, MD, Frederick Hagemeister, MD, Brett Wegner, Otilia Dumitrescu, MD, Neetha Pandit Tasker, MD, Craig H Moskowitz, MD, Andrew D Zelenetz, MD, PhD

Blood (2010) 116 (21): 1793.

https://doi.org/10.1182/blood.V116.21.1793.1793

Published: 2010

Journal Articles

Differential Prevalence of Anti-Heparin-Platelet Factor 4 Antibodies In Elderly Patients with Acute Hip Fracture Undergoing Orthopaedic Surgery and Anticoagulated with Unfractionated Heparin and Enoxaparin

Christopher Song, Josephine Cunanan, MD, Hussein Kahn, M.D., Debra Hoppensteadt, Ph.D., Jawed Fareed, PhD

Blood (2010) 116 (21): 4217.

https://doi.org/10.1182/blood.V116.21.4217.4217

Published: 2010

Journal Articles

Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS): The Principal Results

Jeffrey L Carson, MD, Michael L Terrin, MD, MPH, Jay Magaziner, PhD, David Sanders, MD, Donald R Cook, MD, Kevin Hildebrand, MD

Blood (2009) 114 (22): LBA-6.

https://doi.org/10.1182/blood.V114.22.LBA-6.LBA-6

Published: 2009

Journal Articles

Analysis of Increased Blood Transfusions in U.S. Hospitals, 1997 – 2006.

Chaya T. Merrill, MPH, DrPH(c), Jeffery L Miller, MD, Claudia Steiner, MD, MPH

Blood (2008) 112 (11): 1302.

https://doi.org/10.1182/blood.V112.11.1302.1302

Published: 2008

Journal Articles

Baseline Osteopenia and Osteoporosis in Untreated Non-Hodgkin’s Lymphoma Patients.

Michael A. Thompson, MD, PhD, Auris Huen, PharmD, Gregory D. Ayers, MS, Bela B. Toth, DDS, Rena V. Sellin, MD, Ana O. Hoff, MD, William A. Murphy, Jr., MD, F.B. Hagemeister, MD

Blood (2006) 108 (11): 4607.

https://doi.org/10.1182/blood.V108.11.4607.4607

Published: 2006

NARROW

Delayed Time to Emergency Hip Surgery in Patients Taking Oral Anticoagulants

First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Risk Factors of Thromboembolic Disease in Men with Prostate Cancer: Report from a Hispanic Population

Venetoclax (Ven) with Azacitidine (Aza) for Untreated Elderly Acute Myeloid Leukemia (AML) Patients (Pts) Unfit for Induction Chemotherapy: Single Center Clinical Experience and Mechanistic Insights from Correlative Studies

Increased Fracture Risk in Patients with Untreated Chronic Lymphocytic Leukemia (CLL): A Population-Based Analysis

The Cardiovascular Impact of Carfilzomib in Multiple Myeloma

Treatment Outcomes in Pediatric Patients with Pulmonary Embolism Using Low Dose Tissue Plasminogen Activator Therapy

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer

A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

Incidence Of Symptomatic Venous Thromboembolism In Patients With Hemophilia Undergoing Joint Replacement Surgery: A Retrospective Study

Increased Heparanase Level and Procoagulant Activity in Orthopedic Surgery Patients Receiving Prophylactic Dose of Enoxaparin,

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Combination Therapy with Vorinostat and Bortezomib in Patients with High Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Final Results of a Phase II Study of Sequential R-CHOP and Yttrium-90 Ibritumomab Tiuxetan (RIT) for Elderly High Risk Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL).

Differential Prevalence of Anti-Heparin-Platelet Factor 4 Antibodies In Elderly Patients with Acute Hip Fracture Undergoing Orthopaedic Surgery and Anticoagulated with Unfractionated Heparin and Enoxaparin

Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS): The Principal Results

Analysis of Increased Blood Transfusions in U.S. Hospitals, 1997 – 2006.

Baseline Osteopenia and Osteoporosis in Untreated Non-Hodgkin’s Lymphoma Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only